NM_004525.3:c.11498-154G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004525.3(LRP2):​c.11498-154G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.906 in 152,276 control chromosomes in the GnomAD database, including 62,638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.91 ( 62638 hom., cov: 32)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.107

Publications

11 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 2-169168830-C-T is Benign according to our data. Variant chr2-169168830-C-T is described in ClinVar as Benign. ClinVar VariationId is 1245516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.942 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.11498-154G>A
intron
N/ANP_004516.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.11498-154G>A
intron
N/AENSP00000496870.1
LRP2
ENST00000649153.1
n.2396-154G>A
intron
N/AENSP00000497617.1
LRP2
ENST00000650252.1
n.530-154G>A
intron
N/AENSP00000496887.1

Frequencies

GnomAD3 genomes
AF:
0.906
AC:
137834
AN:
152158
Hom.:
62582
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.950
Gnomad AMI
AF:
0.900
Gnomad AMR
AF:
0.927
Gnomad ASJ
AF:
0.911
Gnomad EAS
AF:
0.737
Gnomad SAS
AF:
0.915
Gnomad FIN
AF:
0.850
Gnomad MID
AF:
0.940
Gnomad NFE
AF:
0.895
Gnomad OTH
AF:
0.915
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.906
AC:
137949
AN:
152276
Hom.:
62638
Cov.:
32
AF XY:
0.903
AC XY:
67273
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.950
AC:
39470
AN:
41552
American (AMR)
AF:
0.927
AC:
14195
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.911
AC:
3159
AN:
3466
East Asian (EAS)
AF:
0.737
AC:
3808
AN:
5168
South Asian (SAS)
AF:
0.914
AC:
4410
AN:
4824
European-Finnish (FIN)
AF:
0.850
AC:
9016
AN:
10608
Middle Eastern (MID)
AF:
0.942
AC:
277
AN:
294
European-Non Finnish (NFE)
AF:
0.895
AC:
60855
AN:
68030
Other (OTH)
AF:
0.916
AC:
1938
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
661
1322
1982
2643
3304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.901
Hom.:
115125
Bravo
AF:
0.909
Asia WGS
AF:
0.859
AC:
2987
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.75
DANN
Benign
0.57
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239602; hg19: chr2-170025340; API